{"title": "LibGuides: York Region COVID-19 Guidance: Vaccine Safety", "author": "Maria Aulicino", "url": "https://guides.hsict.library.utoronto.ca/c.php?g=716417&p=5211249", "hostname": "utoronto.ca", "description": "An online repository of guidance documents relevant to COVID-19 for use of York Region Public Health", "sitename": "Springshare", "date": "2020-04-17", "cleaned_text": "Skip to Main Content Health Science Information Consortium of Toronto LibGuides The Regional Municipality of York York Region COVID-19 Guidance Vaccine Safety Search this Guide Search York Region COVID-19 Guidance An online repository of guidance documents relevant to COVID-19 for use of York Region Public Health Home Ontario Ministry Guidance IOB resources General Acute Care Assessment/Assessment Clinics Communications Community Care / Transmission Toggle Dropdown Pharmacies COVID-19 Variants Dental Care Diagnosis Epidemiology Toggle Dropdown Surveillance Transmission Forecasting Seasonality Ethics Farms & Migrant Workers Food Premises Toggle Dropdown Food Safety Health Care Workers Health Emergency Planning Toggle Dropdown Paramedics Home Care Infodemics IPAC Measures Toggle Dropdown PPE Infection Control Disinfection Face Masks Laboratories Toggle Dropdown Testing and Results Specifications Long Covid Long Term Care Homes Mass Gatherings Toggle Dropdown Religious Services Mental Health Palliative Care Pets Post Exposure Toggle Dropdown Self-Monitoring Quarantine Post-Pandemic Planning Postmortem Guidance Prisons Public Health Schools Toggle Dropdown Childcare Postsecondary Treatment Vaccination Planning Vaccine Safety Vulnerable Populations Toggle Dropdown Addictions Children Chronic Conditions Health Equity Homelessness ImmunoCompromised Conditions Pregnancy Seniors Women Water and Wastewater Workplaces CANADIAN Government of Canada COVID-19 VACCINE-ASSOCIATED MYOCARDITIS/PERICARDITIS [Office of the Chief Science Advisor of Canada Jul 16 2021] Reported side effects following COVID-19 vaccination in Canada [PHAC, Latest Update Oct 18 2021] Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqu\u00e9 to health practitioners (June 3, 2021) Statement from the Council of Chief Medical Officers of Health (CCMOH): Update on COVID-19 Vaccines and the Risk of Myocarditis and Pericarditis [PHAC Oct 1 2021] Government of Ontario COVID-19 Resources [Provincial Council for Maternal and Child Health] Other Alberta COVID-19 Immunization in Pregnancy Factsheet for Practitioners - Update [Sep 21 2021] AT A GLANCE Myocarditis and Pericarditis Following COVID19 mRNA Vaccines [2nd revision Oct 1 2021] Building confidence in COVID-19 vaccines [CMA ] Clinical guidance for youth with myocarditis and pericarditis following mRNA COVID-19 Vaccination [Canadian Paediatric Society Sep 1 2021] COVID-19 Vaccination and Dialysis Patients: An Evolving Story (webinar) [PHO Dec 9 2021] COVID-19 Vaccine: Frequently Asked Questions [Regional Fertility Program May 6 2021] COVID-19 Vaccine and Kids (Webinar) [CAMH, Nov 23 2021] EVIDENCE BRIEF COVID-19 Vaccines and Fertility [PHO Aug 19 2021] FOCUS ON Myocarditis and Pericarditis after COVID-19 mRNA Vaccines [PHO Nov 2021] I am pregnant or breastfeeding. Should I get the COVID-19 Vaccine? [PCMCH V5 Updated Jan 25 2022] Myocarditis & Pericarditis after mRNA vaccination for Covid-19: What it is and what we know. [Ontario Family Physicians] Myocarditis and/or Pericarditis following Myocarditis and pericarditis after mRNA vaccination in children: Interim guidance document [Sick Kids V3.3 Aug 6 2021] PRIMER. Building Confidence in Vaccines [PHO 2021] SYNOPSIS Review of \"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico\" [PHO Oct 13 2021] SYNOPSIS Review of \"Safety of BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Setting\" [PHO Sep 2 2021] SYNTHESIS COVID-19 Viral Vector Vaccines and Rare Blood Clots - Vaccine Safety Surveillance In Action [PHO Jul 12, 2021] Tools For Practice CO-KID: What are the benefits and harms of the available COVID-19 vaccines for children and adolescents? [PEER Nov 24 2021] SURVEILLANCE REPORT Adverse Events Following Immunization (AEFIs) for COVID-19 in Ontario: December 13, 2020 to current INTERNATIONAL Centers for Disease Control and Prevention (CDC) Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data \u2014 United States, March 2020-January 2021 [MMWR Sep 3 2021] CDC Recommends Use of Johnson & Johnson's Janssen COVID-19 Vaccine Resume [Nov 15 2021] Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults [Last updated Nov 9 2021] COVID-19 mRNA vaccines in adolescents and young adults: Benefit-risk discussion [CDC Jun 23 2021] COVID-19 Vaccine Safety in Children Aged 5-11 Years \u2014 United States, November 3-December 19, 2021 [MMWR Dec 31 2021] COVID-19 Vaccination and Non-COVID-19 Mortality Risk \u2014 Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021 [MMWR Oct 29 2021] COVID-19 Vaccines for People Who Would Like to Have a Baby [Updated Dec 6 2021] COVID-19 Vaccines for People with Underlying Medical Conditions [Updated Dec 15 2021] Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years \u2014 United States, June-September 2021 [MMWR Oct 22 2021] Investigating Long-Term Effects of Myocarditis [Updated Aug 20 2021] Johnson & Johnson's Janssen COVID-19 Vaccine Overview and Safety [Updated Dec 28 2021] Moderna COVID-19 Vaccine Overview and Safety [Updated Oct 28 2021] Myocarditis and Pericarditis After mRNA COVID-19 Vaccination [Updated Nov 12 2021] Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY) Overview and Safety [Updated Jan 6 2022] Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth \u2014 Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021 [MMWR Jan 7 2022] Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization \u2014 United States, March 2020-September 2021 [MMWR Nov 26 2021] Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices \u2014 United States, June 2021 [MMWR Jul 9 2021] European Centre for Disease Control (ECDC) World Health Organization COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines [WHO Jul 9 2021] Other About the COVID-19 Vaccine: Frequently Asked Questions [American Academy of Pediatrics] Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms [AJOG Oct 2021] Jun 22 2022] COVID-19 vaccine and infertility: baseless claims and unfounded social media panic [ASRM Jan 19 2021] COVID-19 vaccination - Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines [Australian Government Dept of Health] Last updated Nov 9 2021 In brief COVID-19 vaccines and fertility [NSW Health Sep 16 2021] Joint Statement Regarding COVID-19 Vaccine in Men Desiring Fertility from the Society for Male Reproduction and Urology (SMRU) and the Society for the Study of Male Reproduction (SSMR) {ASRM Jan 2021] SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility [F&S Reports Sep 2021] UPDATE No. 16 - Reproductive Facts Regarding COVID-19 Vaccination [ASRM Jul 23 2021] PUBLIC HEALTH UNITS << Previous: Vaccination Planning Next: Vulnerable Populations >> Last Updated: Jul 13, 2023 8:59 AM URL: "}